<?xml version="1.0" encoding="UTF-8"?>
<drug type="biotech" created="2016-10-17" updated="2019-12-02">
  <drugbank-id primary="true">DB11631</drugbank-id>
  <name>Eptotermin Alfa</name>
  <description>A bone morphogenetic protein that is widely expressed during EMBRYONIC DEVELOPMENT. It is both a potent osteogenic factor and a specific regulator of nephrogenesis. Eptotermin Alfa is an ingredient in the EMA-withdrawn product Osigraft.</description>
  <cas-number>129805-33-0</cas-number>
  <unii>IT063R5MY0</unii>
  <groups>
    <group>approved</group>
    <group>investigational</group>
    <group>withdrawn</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication/>
  <pharmacodynamics/>
  <mechanism-of-action/>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description/>
    <direct-parent>Peptides</direct-parent>
    <kingdom>Organic Compounds</kingdom>
    <superclass>Organic Acids</superclass>
    <class>Carboxylic Acids and Derivatives</class>
    <subclass>Amino Acids, Peptides, and Analogues</subclass>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="english" coder="">BMP-7</synonym>
    <synonym language="english" coder="">Bone morphogenetic protein 7</synonym>
    <synonym language="spanish" coder="">Eptotermina alfa</synonym>
    <synonym language="english" coder="">HBMP7</synonym>
    <synonym language="english" coder="">HrBMP-7</synonym>
    <synonym language="english" coder="">Human recombinant bone morphogenetic protein 7</synonym>
    <synonym language="english" coder="">OP-1</synonym>
    <synonym language="english" coder="">Osteogenic protein 1</synonym>
    <synonym language="english" coder="">RH-polypeptide-52</synonym>
  </synonyms>
  <products>
    <product>
      <name>Opgenra</name>
      <labeller>Olympus Biotech International Limited</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000819</ema-product-code>
      <ema-ma-number>EU/1/08/489/001</ema-ma-number>
      <started-marketing-on>2009-02-19</started-marketing-on>
      <ended-marketing-on>2016-07-14</ended-marketing-on>
      <dosage-form/>
      <strength>3.5 mg</strength>
      <route/>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Opgenra</name>
      <labeller>Olympus Biotech International Limited</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000819</ema-product-code>
      <ema-ma-number>EU/1/08/489/002</ema-ma-number>
      <started-marketing-on>2009-02-19</started-marketing-on>
      <ended-marketing-on>2016-07-14</ended-marketing-on>
      <dosage-form/>
      <strength>3.5 mg</strength>
      <route/>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Osigraft</name>
      <labeller>Olympus Biotech International Limited</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000293</ema-product-code>
      <ema-ma-number>EU/1/01/179/001</ema-ma-number>
      <started-marketing-on>2001-05-17</started-marketing-on>
      <ended-marketing-on>2016-07-27</ended-marketing-on>
      <dosage-form/>
      <strength>3.3 mg</strength>
      <route/>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Osigraft</name>
      <ingredients>Eptotermin Alfa</ingredients>
    </mixture>
    <mixture>
      <name>Opgenra</name>
      <ingredients>Eptotermin Alfa</ingredients>
    </mixture>
    <mixture>
      <name>Opgenra</name>
      <ingredients>Eptotermin Alfa</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Amino Acids, Peptides, and Proteins</category>
      <mesh-id>D000602</mesh-id>
    </category>
    <category>
      <category>Biological Factors</category>
      <mesh-id>D001685</mesh-id>
    </category>
    <category>
      <category>Bone Morphogenetic Proteins</category>
      <mesh-id>D019485</mesh-id>
    </category>
    <category>
      <category>Drugs Affecting Bone Structure and Mineralization</category>
      <mesh-id/>
    </category>
    <category>
      <category>Drugs for Treatment of Bone Diseases</category>
      <mesh-id/>
    </category>
    <category>
      <category>Intercellular Signaling Peptides and Proteins</category>
      <mesh-id>D036341</mesh-id>
    </category>
    <category>
      <category>Musculo-Skeletal System</category>
      <mesh-id/>
    </category>
    <category>
      <category>Peptides</category>
      <mesh-id>D010455</mesh-id>
    </category>
    <category>
      <category>Proteins</category>
      <mesh-id>D011506</mesh-id>
    </category>
    <category>
      <category>TGF-beta Superfamily Proteins</category>
      <mesh-id>D055411</mesh-id>
    </category>
  </categories>
  <affected-organisms/>
  <dosages>
    <dosage>
      <form/>
      <route/>
      <strength>3.5 mg</strength>
    </dosage>
    <dosage>
      <form/>
      <route/>
      <strength>3.3 mg</strength>
    </dosage>
  </dosages>
  <atc-codes>
    <atc-code code="M05BC02">
      <level code="M05BC">Bone morphogenetic proteins</level>
      <level code="M05B">DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION</level>
      <level code="M05">DRUGS FOR TREATMENT OF BONE DISEASES</level>
      <level code="M">MUSCULO-SKELETAL SYSTEM</level>
    </atc-code>
  </atc-codes>
  <ahfs-codes/>
  <pdb-entries/>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <sequences/>
  <experimental-properties/>
  <external-identifiers>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Bone_morphogenetic_protein_7</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL2108594</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>